Mibac

Clindamycin, the active ingredient in Mibac, is an antibiotic and keratolytic combination presented as a topical formulation for skin use. It treats acne vulgaris in adolescents and adults by reducing bacterial growth and promoting exfoliation of clogged pores. The formulation combines clindamycin with benzoyl peroxide, providing both antibacterial and keratolytic actions that help clear existing lesions and prevent new ones.

GNH USA supplies Mibac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Mibac is used in the treatment of acne, targeting the bacterial and keratinocyte processes that contribute to lesion formation.

- Acne vulgaris: reduces inflammatory lesions and comedones, improving skin appearance. - Mild to moderate acne: decreases papules and pustules while preventing new lesion development. - Post‑acne maintenance: helps maintain clear skin after initial therapy by limiting bacterial regrowth.

Topical application of Mibac may be associated with local skin reactions.

Common Side Effects: - Irritation: mild redness or stinging at the application site. - Dryness: peeling or flaking of the treated skin. - Itching: transient pruritus after use. - Burning sensation: temporary warmth or burning feeling.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, or blistering. - Photosensitivity: increased sensitivity to sunlight causing burns. - Severe skin ulceration: deep sores or necrosis at the application site.

When using Mibac, certain precautions should be observed to minimise risk and ensure effective therapy. - Avoid excessive use: apply only as directed to prevent skin irritation. - Do not combine with other topical acne products containing retinoids or salicylic acid unless advised. - Discontinue if severe irritation occurs: seek medical advice. - Use sunscreen: benzoyl peroxide can increase photosensitivity. - Pregnancy and lactation: consult healthcare professional before use. - Store at room temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Mibac may interact with certain topical or systemic agents; awareness of these interactions helps avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Concurrent use with oral antibiotics that share similar resistance profiles may diminish clindamycin effectiveness. - Combining with other potent keratolytic agents (e.g., high‑strength salicylic acid) can cause severe skin irritation. - Use with systemic retinoids may increase risk of skin dryness and irritation.

Moderate Interactions (Monitor Closely): - Application with other topical antibiotics may increase risk of bacterial resistance. - Use with skin lightening agents may alter drug absorption. - Concurrent use of photosensitizing drugs (e.g., tetracyclines) may enhance photosensitivity.